# Teclistamab (Genetical Recombination) S.C. Injection 153mg (テクベイリ皮下注１５３ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 4291475A2020). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 4291475A2020
- **Product name (Japanese):** テクベイリ皮下注１５３ｍｇ
- **English title:** Teclistamab (Genetical Recombination) S.C. Injection 153mg
- **Active ingredient:** テクリスタマブ（遺伝子組換え）
- **Active ingredient (INN):** Teclistamab (Genetical Recombination)
- **Strength / unit:** １５３ｍｇ１．７ｍＬ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 42 Antineoplastics (腫瘍用薬) › 429 Other antineoplastics (その他の腫瘍用薬)
- **Manufacturer:** Janssen Pharmaceutical (ヤンセンファーマ)
- **NHI price (reference only):** JPY 1081023 per １５３ｍｇ１．７ｍＬ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/4291475A2020
- **JSON:** https://www.nifujipharma.com/api/drugs/4291475A2020

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Teclistamab%20(Genetical%20Recombination)%20S.C.%20Injection%20153mg%20(%E3%83%86%E3%82%AF%E3%83%99%E3%82%A4%E3%83%AA%E7%9A%AE%E4%B8%8B%E6%B3%A8%EF%BC%91%EF%BC%95%EF%BC%93%EF%BD%8D%EF%BD%87)%20%2F%20YJ%204291475A2020#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Teclistamab (Genetical Recombination)

- [Teclistamab (Genetical Recombination) S.C. Injection 30mg (テクベイリ皮下注３０ｍｇ)](https://www.nifujipharma.com/drugs/4291475A1023) — ３０ｍｇ３ｍＬ１瓶, Janssen Pharmaceutical